Washington, D.C. – The Board of Pharmacy Specialties (BPS) the premier post-licensure certification organization serving the pharmacy profession, announced the results of the April/May 2023 certification and recertification examination administration window.
In this administration window, a total of 2,547 out of 3,961 examinees were successful in one of eleven certification examinations and seven recertification examinations offered. Results for continuously available examinations BCCP, BCNP, and BCPP certification and recertification examinations will be available in January 2024.
“As the community of board-certified pharmacists grows, it’s important to note that this trend is reflective of the pharmacy profession. Pharmacists, including board-certified pharmacists, play an increasingly important role in the evolving world of health care. Our stakeholders recognize that specialized knowledge and pharmacist certification is important to providing the highest level of patient care across many patient care settings.” said BPS Executive Director, William M. Ellis, MS, RPh, ICE-CCP.
Recertification examinations were not offered in the following specialties, as the initial cohort of certificants have not yet reached year 7 in their certification cycle: cardiology pharmacy (BCCP), compounded sterile preparations pharmacy (BCSCP), infectious diseases pharmacy (BCIDP), solid organ transplantation pharmacy (BCTXP), and emergency medicine pharmacy (BCEMP). Recertification examinations will begin in 2025 for BCCP and BCIDP, 2026 for BCSCP, 2028 for BCTXP, and 2030 for BCEMP.
The results for each examination program are provided below and are organized by the breakdown of total exam candidates (inclusive of first-time and repeat attempts) followed by first-time attempt candidates.
April/May 2023 Certification and Recertification examination results by specialty:
About the Board of Pharmacy Specialties
The Board of Pharmacy Specialties (BPS) was established in 1976 as an autonomous division of the American Pharmacists Association (APhA). The mission of BPS is to improve patient care by positioning BPS Board-Certified Pharmacist Specialists as integral members of interprofessional healthcare teams, through recognition and promotion of specialized training, knowledge, and skills for pharmacists in the United States and internationally. Board certification is a recognized credential for determining which pharmacists are qualified to contribute at advanced practice levels given the rigorous standards mandated by BPS board certification and recertification. BPS currently recognizes more than 58,800 active pharmacist certifications across 14 specialties.
BPS Contact
Alexander Jean-Baptiste
Senior Manager, Content Marketing & Social Media
ajeanbaptiste@aphanet.org
(202) 760-3836